Tekla Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $59.6M | Sell |
1,624,476
-150,600
| -8% | -$5.86M | 2.33% | 14 |
|
|
2023
Q1 | $72.4M | Buy |
1,775,076
+317,906
| +22% | +$13.7M | 2.76% | 10 |
|
|
2022
Q4 | $74.7M | Buy |
1,457,170
+325,067
| +29% | +$15.6M | 2.82% | 10 |
|
|
2022
Q3 | $49.5M | Hold |
1,132,103
| – | – | 2.03% | 15 |
|
|
2022
Q2 | $59.4M | Sell |
1,132,103
-39,800
| -3% | -$2.03M | 2.33% | 12 |
|
|
2022
Q1 | $60.7M | Hold |
1,171,903
| – | – | 2.13% | 13 |
|
|
2021
Q4 | $69.2M | Buy |
1,171,903
+721,524
| +160% | +$35.7M | 2.23% | 11 |
|
|
2021
Q3 | $19.4M | Hold |
450,379
| – | – | 0.62% | 47 |
|
|
2021
Q2 | $17.6M | Sell |
450,379
-254,880
| -36% | -$9.91M | 0.57% | 47 |
|
|
2021
Q1 | $25.6M | Hold |
705,259
| – | – | 0.88% | 28 |
|
|
2020
Q4 | $26M | Sell |
705,259
-1,082,080
| -61% | -$39.7M | 0.91% | 31 |
|
|
2020
Q3 | $62.2M | Buy |
1,787,339
+41,337
| +2% | +$1.45M | 2.33% | 10 |
|
|
2020
Q2 | $54.2M | Sell |
1,746,002
-172,539
| -9% | -$5.86M | 2.06% | 11 |
|
|
2020
Q1 | $59.4M | Sell |
1,918,541
-279,416
| -13% | -$9.52M | 2.69% | 9 |
|
|
2019
Q4 | $81.7M | Sell |
2,197,957
-30,522
| -1% | -$1.09M | 3.09% | 8 |
|
|
2019
Q3 | $76M | Buy |
2,228,479
+48,528
| +2% | +$1.76M | 3.31% | 7 |
|
|
2019
Q2 | $89.6M | Sell |
2,179,951
-2,635
| -0.1% | -$105K | 3.66% | 6 |
|
|
2019
Q1 | $87.9M | Buy |
2,182,586
+583,886
| +37% | +$23.4M | 3.57% | 5 |
|
|
2018
Q4 | $66.2M | Buy |
1,598,700
+171,486
| +12% | +$7.12M | 2.83% | 9 |
|
|
2018
Q3 | $59.7M | Sell |
1,427,214
-1,059,896
| -43% | -$40.8M | 2.16% | 11 |
|
|
2018
Q2 | $85.6M | Buy |
2,487,110
+324,362
| +15% | +$11.1M | 3.25% | 8 |
|
|
2018
Q1 | $72.8M | Buy |
2,162,748
+1,135,006
| +110% | +$39M | 2.83% | 8 |
|
|
2017
Q4 | $35.3M | Buy |
1,027,742
+173,910
| +20% | +$5.93M | 1.36% | 17 |
|
|
2017
Q3 | $28.9M | Hold |
853,832
| – | – | 1.03% | 27 |
|
|
2017
Q2 | $27.2M | Sell |
853,832
-354,778
| -29% | -$11.2M | 1.01% | 25 |
|
|
2017
Q1 | $39.2M | Hold |
1,208,610
| – | – | 1.52% | 21 |
|
|
2016
Q4 | $37.2M | Hold |
1,208,610
| – | – | 1.59% | 18 |
|
|
2016
Q3 | $38.8M | Sell |
1,208,610
-354,779
| -23% | -$11.9M | 1.49% | 21 |
|
|
2016
Q2 | $52.2M | Sell |
1,563,389
-346,471
| -18% | -$11.1M | 2.13% | 10 |
|
|
2016
Q1 | $53.7M | Buy |
1,909,860
+10,245
| +0.5% | +$293K | 2.28% | 10 |
|
|
2015
Q4 | $58.2M | Hold |
1,899,615
| – | – | 2.11% | 13 |
|
|
2015
Q3 | $56.6M | Buy |
1,899,615
+172,909
| +10% | +$5.54M | 2.03% | 14 |
|
|
2015
Q2 | $54.9M | Hold |
1,726,706
| – | – | 1.99% | 15 |
|
|
2015
Q1 | $57M | Hold |
1,726,706
| – | – | 2.26% | 12 |
|
|
2014
Q4 | $51M | Sell |
1,726,706
-278,256
| -14% | -$7.98M | 2.39% | 13 |
|
|
2014
Q3 | $56.2M | Buy |
2,004,962
+1,651,917
| +468% | +$46.4M | 2.64% | 9 |
|
|
2014
Q2 | $9.94M | Buy |
+353,045
| New | +$10.1M | 0.91% | 32 |
|
Other funds holding PFE
Tekla Capital Management's PFE Position: Q2 2023 in Review
Tekla Capital Management reduced its Pfizer (PFE) stake by 8.5% in Q2 2023, selling an estimated $5.86M and leaving 1,624,476 shares worth $59.6M. The position accounts for 2.33% of the portfolio, ranked #14.
Tekla Capital Management first reported a position in PFE in Q2 2014 and has held it in 37 quarters since. The position peaked at $89.6M in Q2 2019. 3,042 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Tekla Capital Management held 1,624,476 shares of Pfizer worth $59.6M as of Q2 2023.
- Tekla Capital Management sold 150,600 Pfizer shares in Q2 2023, an estimated $5.86M.
- Pfizer made up 2.33% of Tekla Capital Management's portfolio in Q2 2023, its #14 holding.
- Tekla Capital Management first reported a position in Pfizer in Q2 2014 and has held it in 37 quarters since.
- Tekla Capital Management's Pfizer position peaked at $89.6M in Q2 2019.
- 3,042 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.